investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Leukaemia

Pathology

Dong-Er Zhang

Molecular Mechanism of Leukemogenesis Involving AML1-ETO

Leukaemia

Pathology Hematology and hematologic malignancies

Jon C Aster

Oncogenic Notch Signaling

Leukaemia

Pathology Hematology and hematologic malignancies

Julia Kubanek

Ecological Leads for Drug Discovery from Marine Organisms

Leukaemia

Amy Paguirigan

Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia

Leukaemia

Catherine Ju-Ying Wu

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

Leukaemia

Paul B. Jacobsen

Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue

Leukaemia

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma Hodgkin lymphoma

Pathology

Keisuke Nagao

Exploring Mechanisms that Govern Immune Homeostasis in Skin

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies